Theranos Crackdown Benefits: Charts
Theranos Crackdown Benefits: Charts
(Bloomberg Gadfly) -- Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly; sign up here. From a global water imbalance to a Spotify shift, here are four charts that tell you what you need to know in business today.
And don't miss Sarah Halzack on Carl Icahn's cookware investment: "It was shrewd for Newell to join forces with Icahn. By accepting several new members to its board, the company now can make a convincing case to shareholders that it is plenty open to fresh ideas and outside help. It's harder to argue now that Newell is simply resisting Starboard's nominees out of stubbornness. But I don't think it'll be smooth sailing from here for Newell's Starboard pushback. That's because shareholders are rightly looking for more evidence Newell doesn't need Starboard's help."
This column does not necessarily reflect the opinion of Bloomberg LP and its owners.
Max Nisen is a Bloomberg Gadfly columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.
To contact the editor responsible for this story: Mark Gongloff at mgongloff1@bloomberg.net.
©2018 Bloomberg L.P.